The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells
Version of Record online: 3 SEP 2012
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
European Journal of Immunology
Volume 42, Issue 11, pages 2889–2900, November 2012
How to Cite
Zhan, Y., Vega-Ramos, J., Carrington, E. M., Villadangos, J. A., Lew, A. M. and Xu, Y. (2012), The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells. Eur. J. Immunol., 42: 2889–2900. doi: 10.1002/eji.201242477
- Issue online: 29 OCT 2012
- Version of Record online: 3 SEP 2012
- Accepted manuscript online: 18 JUL 2012 01:47AM EST
- Manuscript Accepted: 12 JUL 2012
- Manuscript Revised: 7 JUN 2012
- Manuscript Received: 19 FEB 2012
- National Health and Medical Research Council of Australia (NHMRC). Grant Numbers: #1006428, #637324, #1007703, #516700
- Juvenile Diabetes Research Foundation. Grant Number: #112613
- NHMRC Independent Research Institutes Infrastructure
- Victorian State Government Operational Infrastructure
Disclaimer: Supplementary materials have been peer-reviewed but not copyedited.
Figure 1. Signaling of GM-CSF on DC development.
Figure 2. (A) Antigen presentation by BM-DCs.
Figure 3. Expression of IRF8 by DC subsets.
Figure 4. Limiting dilution of DC development from pro-DCs.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.